
Petra Capital Partners
Description
Petra Capital Partners is a Nashville-based private equity firm established in 1996, specializing in providing growth capital to lower middle-market companies. With over two decades of experience, the firm primarily targets businesses within the healthcare, business services, and technology-enabled services sectors. Their investment strategy focuses on partnering with management teams of companies that demonstrate strong growth potential and typically have EBITDA ranging from $3 million to $15 million, indicating their focus on established, yet growing, enterprises.
Petra Capital Partners employs a disciplined investment approach, aiming to support companies through various growth stages, including organic expansion, strategic acquisitions, and market penetration. The firm is known for its flexible capital solutions, which can include both equity and subordinated debt. Typically, Petra commits between $10 million and $30 million of equity capital per transaction, making them a significant partner for companies seeking substantial growth funding to scale operations or pursue strategic initiatives.
The firm has a strong track record of successful fundraises, demonstrating consistent investor confidence. Their most recent fund, Petra Growth Fund VI, closed in 2023 with $300 million in commitments, following Petra Growth Fund V which closed at $255 million in 2018, and Petra Growth Fund IV which closed at $200 million in 2014. These successive fund increases highlight the firm's expanding capacity and commitment to its investment strategy. Petra Capital Partners emphasizes a collaborative partnership model, leveraging its extensive network and operational expertise to help portfolio companies achieve their strategic objectives and maximize long-term value.
Investor Profile
Petra Capital Partners has backed more than 22 startups, with 1 new investments in the last 12 months alone. The firm has led 11 rounds, about 50% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series A, Private Equity rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Health Care, Information Technology, Medical.
- Typical check size: $10M – $30M.
Stage Focus
- Series Unknown (45%)
- Series A (23%)
- Private Equity (18%)
- Series C (5%)
- Debt Financing (5%)
- Series D (5%)
Country Focus
- United States (95%)
- United Kingdom (5%)
Industry Focus
- Health Care
- Information Technology
- Medical
- Biotechnology
- Hospital
- Software
- Health Diagnostics
- Government
- Consulting
- Education
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.